2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy.

Proceedings of the National Academy of Sciences of the United States of America
Silvia TerésPablo V Escriba

Abstract

Despite recent advances in the development of new cancer therapies, the treatment options for glioma remain limited, and the survival rate of patients has changed little over the past three decades. Here, we show that 2-hydroxyoleic acid (2OHOA) induces differentiation and autophagy of human glioma cells. Compared to the current reference drug for this condition, temozolomide (TMZ), 2OHOA combated glioma more efficiently and, unlike TMZ, tumor relapse was not observed following 2OHOA treatment. The novel mechanism of action of 2OHOA is associated with important changes in membrane-lipid composition, primarily a recovery of sphingomyelin (SM) levels, which is markedly low in glioma cells before treatment. Parallel to membrane-lipid regulation, treatment with 2OHOA induced a dramatic translocation of Ras from the membrane to the cytoplasm, which inhibited the MAP kinase pathway, reduced activity of the PI3K/Akt pathway, and downregulated Cyclin D-CDK4/6 proteins followed by hypophosphorylation of the retinoblastoma protein (RB). These regulatory effects were associated with induction of glioma cell differentiation into mature glial cells followed by autophagic cell death. Given its high efficacy, low toxicity, ease of oral admini...Continue Reading

References

Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·P V EscribáJ A García-Sevilla
Jul 9, 1999·Progress in Lipid Research·F M Goñi, A Alonso
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K YungV A Levin
Oct 2, 2001·Pharmacology & Therapeutics·M LeszczynieckaP B Fisher
Jul 3, 2004·The Journal of Biological Chemistry·Oliver VöglerPablo V Escribá
Sep 17, 2004·Molecular Membrane Biology·Francisca BarcelóPablo V Escribá
Oct 7, 2004·Cell Cycle·Marie C Harrisingh, Alison C Lloyd
Nov 9, 2004·Molecular Pharmacology·Jordi MartínezPablo V Escribá
Nov 30, 2004·Trends in Molecular Medicine·Andrew T Parsa, Eric C Holland
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 20, 2005·The Journal of Pharmacology and Experimental Therapeutics·Jordi MartínezPablo V Escribá
Dec 6, 2005·Trends in Molecular Medicine·Pablo V Escribá
Feb 6, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Michael L H WongChristopher M Hovens
Feb 20, 2007·Biochimica Et Biophysica Acta·Menachem KatzYosef Yarden
Mar 22, 2007·Archives of Biochemistry and Biophysics·Elisabetta Ferraro, Francesco Cecconi
Jun 5, 2007·Biophysical Journal·Francisca BarcelóPablo V Escribá
Jun 9, 2007·Biochimica Et Biophysica Acta·Deborah T LeichtGuri Tzivion
Jul 14, 2007·Cellular and Molecular Life Sciences : CMLS·J OmerovicI A Prior
Nov 28, 2007·Annual Review of Pathology·David N Louis
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hermann BrennerUNKNOWN EUROCARE Working Group
Jan 17, 2009·The Journal of Biological Chemistry·Fabrizio GrifferoGiorgio Corte
Jun 18, 2009·Molecular Cancer Research : MCR·David E ModrakDavid V Gold
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Victoria LladóXavier Busquets
Sep 10, 2009·Cancer Science·Hiroko Ohgaki, Paul Kleihues
Nov 26, 2009·Journal of Cellular Physiology·Ruth G TatevossianDenise Sheer
Feb 10, 2010·Journal of Cellular and Molecular Medicine·Jungsug GwakSangtaek Oh
Apr 27, 2010·Oncogene·F MollinedoM J Blanco-Prieto
Sep 3, 2010·Cancer Research·Hong JiangJuan Fueyo
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Gwendolyn Barceló-CoblijnPablo V Escribá

❮ Previous
Next ❯

Citations

Mar 9, 2013·Journal of Lipid Research·Maria Laura MartinGwendolyn Barceló-Coblijn
Nov 8, 2012·PloS One·Amaia Marcilla-EtxenikeXavier Busquets
Apr 4, 2014·Organic & Biomolecular Chemistry·Fang-Wu WangJun-Ying Miao
Nov 27, 2015·Analytical Chemistry·Roberto FernándezJosé A Fernández
Jan 31, 2013·Biochimica Et Biophysica Acta·Maria Laura MartinPablo V Escribá
Oct 22, 2013·Advances in Biological Regulation·Venkatesh Kota, Hiroko Hama
Jan 28, 2014·Biochimica Et Biophysica Acta·Stefano PiottoSimona Concilio
Mar 19, 2013·Biochimica Et Biophysica Acta·Angelo FontanaPatrizia Polverino de Laureto
Feb 11, 2015·Apoptosis : an International Journal on Programmed Cell Death·Manuel TorresXavier Busquets
Jun 23, 2016·EBioMedicine·Anne-Marie EllegaardMarja Jäättelä
Jul 3, 2016·Biochimica Et Biophysica Acta·Ana Catarina AlvesSalette Reis
Oct 12, 2018·The Journal of Biological Chemistry·Bin LouXian-Cheng Jiang
Dec 19, 2018·The Journal of Biological Chemistry·Bindu LakshmanFrantz L Jean-Francois
May 6, 2019·International Journal of Molecular Sciences·Doralicia CasaresCatalina Ana Rosselló
Jun 13, 2015·The Journal of Pharmacology and Experimental Therapeutics·Francisca Guardiola-SerranoPablo V Escribá
Aug 23, 2019·The Journal of Membrane Biology·Pranav Adhyapak, Shobhna Kapoor
Apr 2, 2020·International Journal of Molecular Sciences·Manuel TorresPablo Vicente Escribá
Aug 28, 2020·Metabolomics : Official Journal of the Metabolomic Society·Inger Ødum NielsenKenji Maeda
Jun 8, 2017·Neurochemical Research·Manasi P JogalekarElba E Serrano
Jul 10, 2019·Molecular Cancer Therapeutics·Atul AnandMarja Jäättelä
Oct 8, 2020·Journal of Lipid and Atherosclerosis·Makoto Taniguchi, Toshiro Okazaki
Jun 1, 2019·Langmuir : the ACS Journal of Surfaces and Colloids·Rama PrajapatiStefan Salentinig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.